Variants in ANKRD55 have been previously described as a risk factor for various autoimmune and inflammatory diseases, such as rheumatoid arthritis, type 1 diabetes, and inflammatory myopathies, which contrastingly to our findings are associated with higher expression of ANKRD55 in CD4+ T lymphocytes [37]. Here, CD4 is linked to type 1 diabetes mellitus.